These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 15579095)
1. Platinum-intercalator conjugates: from DNA-targeted cisplatin derivatives to adenine binding complexes as potential modulators of gene regulation. Baruah H; Barry CG; Bierbach U Curr Top Med Chem; 2004; 4(15):1537-49. PubMed ID: 15579095 [TBL] [Abstract][Full Text] [Related]
2. Cooperative effects in long-range 1,4 DNA-DNA interstrand cross-links formed by polynuclear platinum complexes: an unexpected syn orientation of adenine bases outside the binding sites. Qu Y; Scarsdale NJ; Tran MC; Farrell NP J Biol Inorg Chem; 2003 Jan; 8(1-2):19-28. PubMed ID: 12459895 [TBL] [Abstract][Full Text] [Related]
3. Adenine-N3 in the DNA minor groove - an emerging target for platinum containing anticancer pharmacophores. Guddneppanavar R; Bierbach U Anticancer Agents Med Chem; 2007 Jan; 7(1):125-38. PubMed ID: 17266509 [TBL] [Abstract][Full Text] [Related]
4. Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure. Hegmans A; Berners-Price SJ; Davies MS; Thomas DS; Humphreys AS; Farrell N J Am Chem Soc; 2004 Feb; 126(7):2166-80. PubMed ID: 14971952 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological activity, and DNA-damage profile of platinum-threading intercalator conjugates designed to target adenine. Guddneppanavar R; Saluta G; Kucera GL; Bierbach U J Med Chem; 2006 Jun; 49(11):3204-14. PubMed ID: 16722638 [TBL] [Abstract][Full Text] [Related]
6. Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair. Kostrhunova H; Malina J; Pickard AJ; Stepankova J; Vojtiskova M; Kasparkova J; Muchova T; Rohlfing ML; Bierbach U; Brabec V Mol Pharm; 2011 Oct; 8(5):1941-54. PubMed ID: 21806015 [TBL] [Abstract][Full Text] [Related]
8. Unprecedented monofunctional metalation of adenine nucleobase in guanine- and thymine-containing dinucleotide sequences by a cytotoxic platinum-acridine hybrid agent. Barry CG; Baruah H; Bierbach U J Am Chem Soc; 2003 Aug; 125(32):9629-37. PubMed ID: 12904029 [TBL] [Abstract][Full Text] [Related]
9. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes. Novakova O; Kasparkova J; Malina J; Natile G; Brabec V Nucleic Acids Res; 2003 Nov; 31(22):6450-60. PubMed ID: 14602903 [TBL] [Abstract][Full Text] [Related]
10. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines. Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637 [TBL] [Abstract][Full Text] [Related]
11. Unique structural properties of DNA interstrand cross-links formed by a new antitumor dinuclear Pt(ii) complex. Hrabina O; Kasparkova J; Suchankova T; Novohradsky V; Guo Z; Brabec V Metallomics; 2017 May; 9(5):494-500. PubMed ID: 28436510 [TBL] [Abstract][Full Text] [Related]
12. Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA. Malina J; Natile G; Brabec V Chemistry; 2013 Sep; 19(36):11984-91. PubMed ID: 23873652 [TBL] [Abstract][Full Text] [Related]
13. Transcription inhibition by platinum-DNA cross-links in live mammalian cells. Ang WH; Myint M; Lippard SJ J Am Chem Soc; 2010 Jun; 132(21):7429-35. PubMed ID: 20443565 [TBL] [Abstract][Full Text] [Related]
14. A bifunctional platinum(II) complex capable of intercalation and hydrogen-bonding interactions with DNA: binding studies and cytotoxicity. Ma DL; Che CM Chemistry; 2003 Dec; 9(24):6133-44. PubMed ID: 14679525 [TBL] [Abstract][Full Text] [Related]
15. DNA interaction with novel antitumor estradiol-platinum(II) hybrid molecule: a comparative study with cisplatin drug. N'soukpoé-Kossi CN; Descôteaux C; Asselin E; Tajmir-Riahi HA; Bérubé G DNA Cell Biol; 2008 Feb; 27(2):101-7. PubMed ID: 17970617 [TBL] [Abstract][Full Text] [Related]
16. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent. Brabec V; Kaspárková J; Vrána O; Nováková O; Cox JW; Qu Y; Farrell N Biochemistry; 1999 May; 38(21):6781-90. PubMed ID: 10346899 [TBL] [Abstract][Full Text] [Related]
17. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex. Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702 [TBL] [Abstract][Full Text] [Related]
18. DNA interactions of cisplatin tethered to the DNA minor groove binder distamycin. Loskotová H; Brabec V Eur J Biochem; 1999 Dec; 266(2):392-402. PubMed ID: 10561579 [TBL] [Abstract][Full Text] [Related]
19. DNA metalating-intercalating hybrid agents for the treatment of chemoresistant cancers. Suryadi J; Bierbach U Chemistry; 2012 Oct; 18(41):12926-34. PubMed ID: 22987397 [TBL] [Abstract][Full Text] [Related]
20. Recent advances in multinuclear complexes as potential anticancer and DNA binding agents. Wang K; Gao E Anticancer Agents Med Chem; 2014 Jan; 14(1):147-69. PubMed ID: 23869783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]